...
首页> 外文期刊>癌と化学療法 >A resected case of effective treatment with TS-1 and CDDP for advanced gastric cancer with carcinomatous ascites
【24h】

A resected case of effective treatment with TS-1 and CDDP for advanced gastric cancer with carcinomatous ascites

机译:TS-1和CDDP有效治疗晚期胃癌伴癌性腹水一例

获取原文
获取原文并翻译 | 示例

摘要

We encountered a resected case of advanced gastric cancer after successful chemotherapy. The patient remained alive in good condition without any signs of recurrence at 2 years and 8 months after surgery. The 40-year-old woman initially complained of low abdominal pain, which was diagnosed as gastric cancer with metastasis of ovaries and carcinomatous ascites. We administered TS-1 (100 mg/body/day) for 3 weeks followed by 2-week rest and CDDP (60 mg/body) on the 8th day of one cycle. After 3 cycles of treatment, carcinomatous ascites disappeared and the ovarian lesion was reduced. The patient underwent total gastrectomy, ileocecal resection, cholecystectomy and radical hysterectomy. The antitumor efficacy of the treatment was histologically Grade 2. We administered 17 cycles of TS-1 treatment, and the patient is alive in good condition at this writing. This shows that TS-1 and CDDP may have potent therapeutic efficacy in advanced gastric cancer patients. For the future, the safety and efficacious administration of TS-1 and CDDP should be examined further.
机译:化疗成功后,我们遇到了一例切除的晚期胃癌病例。术后2年和8个月,患者的病情仍然良好,没有任何复发的迹象。这位40岁的女性最初主诉腹痛低,被诊断为胃癌,并伴有卵巢和癌性腹水转移。我们在一个周期的第8天给予TS-1(100毫克/人/天)治疗3周,然后休息2周和CDDP(60毫克/人)。经过3个周期的治疗,癌性腹水消失,卵巢病变减少。该患者接受了全胃切除术,回盲肠切除术,胆囊切除术和根治性子宫切除术。该治疗的抗肿瘤功效在组织学上为2级。我们进行了17个周期的TS-1治疗,该患者在本文撰写时仍处于良好状态。这表明TS-1和CDDP在晚期胃癌患者中可能具有有效的治疗功效。将来,应进一步研究TS-1和CDDP的安全性和有效管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号